Skip to main content
Renalytix Plc (RNLX)
NASDAQ: RNLX · IEX Real-Time Price · USD
0.513
-0.076 (-12.87%)
At close: May 17, 2024, 4:00 PM
0.512
-0.001 (-0.23%)
After-hours: May 17, 2024, 7:59 PM EDT

Renalytix Revenue

Renalytix had revenue of $2.22M in the twelve months ending March 31, 2024, down -40.23% year-over-year. Revenue in the quarter ending March 31, 2024 was $535.00K, a -26.10% decrease year-over-year. In the fiscal year ending June 30, 2023, Renalytix had annual revenue of $3.40M with 14.58% growth.

Revenue (ttm)
$2.22M
Revenue Growth
-40.23%
P/S Ratio
17.81
Revenue / Employee
$21,775
Employees
102
Market Cap
39.55M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20233.40M433.00K14.58%
Jun 30, 20222.97M1.48M99.20%
Jun 30, 20211.49M--
Jun 30, 20200--
Jun 30, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Precision Optics Corporation 19.41M
Cara Therapeutics 16.94M
OncoCyte 1.38M
Cyclo Therapeutics 1.13M
VYNE Therapeutics 423.00K
Revenue Rankings

RNLX News

More News